Navigation Links
Syngenta Enters Into Research Collaboration With Anhui Academy, China
Date:2/10/2009

BASEL, Switzerland, Feb. 10 /PRNewswire/ -- Syngenta today announced that it has agreed an eight-year research collaboration with Anhui Rice Research Institute (ARRI) of Anhui Academy of Agricultural Sciences in China. The collaboration program is centered around conducting laboratory and field tests of novel gene functions and will focus on drought tolerance and nitrogen utilization optimization in key crops such as corn and soybean. ARRI will work closely with Syngenta's new biotech research and technology center in Beijing which was opened in October last year.

"This collaboration will accelerate our research and increase our efficiency and competitiveness," says Xun Wang, Head of Syngenta Biotechnology China. "ARRI has strong expertise and experience in genetics, breeding and field experiments."

The base crop for the program will be rice, which is highly suited for gene research. It is a well characterized crop regarding genetic, molecular and agronomic information and its genome is closely related to those of major crops such as corn. The relatively short growing cycle of rice will also allow more testing to be completed in a shorter time frame.

"We are very excited and honored to be entering into collaboration with Syngenta, a world class agribusiness with global expertise. I strongly believe scientists from both sides will work closely together to develop cutting-edge technologies and provide novel solutions to agriculture," says Jianbo Yang, President of Anhui Academy of Agricultural Sciences.

The research agreement is part of Syngenta's efforts to work closely with Chinese academics. In 2007, Syngenta entered into a five-year research collaboration with the Institute of Genetics and Developmental Biology (IGDB) in Beijing on the development of novel agronomic traits for key crops such as corn, soybean, wheat, sugar beet and sugar cane.

Founded in 1987, ARRI is a lea
'/>"/>

SOURCE Syngenta
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
2. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
3. Syngenta To Build Major Global Biotech Research Center in Beijing, China
4. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
5. Syngenta Licenses Chromatin Gene Stacking Technology
6. Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
7. China Biologic Products Enters into Short-Term Loan Agreement
8. Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG
9. Mach One Corporation Enters Letter of Intent
10. Perceptive Informatics Enters License Agreement With EuroQoL Group to Provide Enhanced Standardization for ePRO Solution
11. Peregrine Pharmaceuticals Enters Into a Loan Agreement for up to $10 Million

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: A...aceutical company focused on endocrine therapy and...Drug Administration (FDA) has granted Fast Track d...bitor compound, perifosine (KRX-0401), for the tre...ryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is...
(Date:12/2/2009)...wswire/ -- According to the National Institute of ...nosed with diabetes already have some stage of dia...o the retina caused by leaky blood vessels, is a m...d is one of the most feared diabetic complications...e had diabetes for 10 years or more will experienc...
(Date:12/1/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Chromium - Global Market Trends ,,...Global-Market-Trends.html ,, Worldwide demand ...steel, while growth in aerospace and industrial ga...chromium metal. Environmental constraints and rapi...
(Date:12/1/2009)...ewswire/ -- Harvest Technologies Corp. ( www.harve...any sponsored 60-patient clinical trial conducted ...a using the company,s BMAC System to treat patient...(CLI). Sri Ramachandra Medical Center is a Harvard...d in Chennai, India and one of the largest private...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
..., EDMONTON, Aug. 1 /PRNewswire-FirstCall/ - BioMS...he treatment of multiple sclerosis (MS), today,ann...n its phase III,clinical trial of MBP8298 (dirucot... (SPMS). The trial, named MAESTRO-03, includes app... 68 trial sites in the U.S., "We have had great s...
...1 /Xinhua-PRNewswire-FirstCall/ --,China Pharma Ho... CPHI),which develops, manufactures, and markets l...ts in China, today announced the Company will host...ednesday, August 6, 2008 to,discuss these results....rlier that same day., Ms. Zhilin Li, President an...
... Aug. 1 Sanofi,Pasteur, the vaccines division of ...cine (Fluzone(R), Influenza Virus Vaccine) in the ...1.3 million doses of influenza,vaccine began shipp...,2008-2009 formulation by the U.S. Food and Drug A...ipments to health-care providers and to the Center...
Other Biology Technology:BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 2BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 3BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 4China Pharma Holdings, Inc. to Host Second Quarter 2008 Earnings Conference Call at 10 a.m. EDT Wednesday August 6, 2008 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 5
(Date:12/2/2009)...adults who are fit have a higher IQ and are more l...study carried out at the Sahlgrenska Academy and S...re published today in the prestigious Proceedings...e study involved 1.2 million Swedish men doing mil... The research group analysed the results of both p...
(Date:12/2/2009)..., REDWOOD CITY, Calif., Dec. 2 ...tity and authentication solutions, today announced...s DigitalPersona biometric fingerprint technology ...ona U.are.U® 4500HD offering allows point-of-...ify users so that specific transactions can be lin...
(Date:12/2/2009)...ientist from the University of Salamanca and anoth...ce of predators affects the behaviour of Acanthod...Negev Desert in the Near East. According to the st...e and different prey if they are under pressure fr...icted this result, but until now there had been ve...
Breaking Biology News(10 mins):Young adults who exercise get higher IQ 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Lizards change their diet to avoid predators 2Matrixx Initiatives Inc Sets Time for Discussion of Recent FDA Action 49292 1Matrixx Initiatives Inc Sets Time for Discussion of Recent FDA Action 49292 2No Matter the Vehicle Sending Text Messages While Driving Increases Risk of Accidents Warns New York Auto Accident Lawyer 49290 1No Matter the Vehicle Sending Text Messages While Driving Increases Risk of Accidents Warns New York Auto Accident Lawyer 49290 2No Matter the Vehicle Sending Text Messages While Driving Increases Risk of Accidents Warns New York Auto Accident Lawyer 49290 3Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference 12680 1
...ntists at Cold Spring Harbor Laboratory have for t... pituitary glands of mice to grow even after birth...cells, these cells are distinct from those that fu... results suggest a novel way that the hormone-secr...lts, to traumatic stress or to normal life changes...
...that patients with sickle cell disease have malfor...ally disc-shaped that can cause sudden painful ep..., researchers at the University of North Carolina ...blood from sickle cell patients also contains clum...at may contribute to the blockages. , The study, ...
...ity] Many of society,s most pressing problems th...e drinking water, rooting out the biomarkers of di...ular and nanoscale level. Such complex research is...tead embraces many disciplines, involving scientis...growing awareness is the impetus behind the new In...
Other Biology News:Scientists find stem cells for the first time in the pituitary 2Scientists find stem cells for the first time in the pituitary 3Clumps of red and white blood cells may contribute to sickle cell disease 2Brown opens institute for molecular and nanoscale innovation 2
...isION Ion Channel Cell Lines ,High Quality, Functi...annels are well known for having a critical role i...a key function in pain, CNS and the heart. Drugs t...n therapeutic areas, such as neuropathic pain, car...
Mouse Anti-Human SLC25A11 Monoclonal Antibody, Unconjugated, Clone 3G4 from Abnova Corporation
Mouse Anti-TOPORS Monoclonal Antibody, Unconjugated, Clone 4G4 from Abnova Corporation
Mouse Anti-Human SNAPC5 Monoclonal Antibody, Unconjugated, Clone 6G10 from Abnova Corporation
Biology Products: